Understanding How Ketamine Brings About Rapid Improvement in OCD (MKET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02624596

Recruitment Status : Active, not recruiting

First Posted : December 8, 2015

Last Update Posted : November 13, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

University of Connecticut

Information provided by (Responsible Party):

Carolyn Rodriguez, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	June 2024
Estimated Study Completion Date :	June 2024

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bandeira ID, Lins-Silva DH, Cavenaghi VB, Dorea-Bandeira I, Faria-Guimaraes D, Barouh JL, Jesus-Nunes AP, Beanes G, Souza LS, Leal GC, Sanacora G, Miguel EC, Sampaio AS, Quarantini LC. Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review. Harv Rev Psychiatry. 2022 Mar-Apr 01;30(2):135-145. doi: 10.1097/HRP.0000000000000330.

To Top